Luo Zhijie, Cai Qin, Zhao Yuanyuan, Wang Xiaochuan, Fu Siying, Zhai Linzhu
Cancer Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine Internal Medicine Center, Sun Yat-sen University Cancer Center Department of Ophthalmology Department of Pathology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, PR China.
Medicine (Baltimore). 2018 May;97(20):e10754. doi: 10.1097/MD.0000000000010754.
Metastases of breast carcinoma to the main bronchus and choroid are rare, but have been reported in relevant literature. Late distant recurrence of breast carcinoma after more than 20 years is extremely rare. Herein, we report a 57-year-old woman with late distant recurrence and metastasis to the main bronchus and choroid almost 28 years after surgery.
At the age of 29, the patient underwent chemotherapy and endocrine treatment after a right side mastectomy to remove breast carcinoma. The patient was hospitalized for a cough with blood-tinged sputum, dysphagia, and blurred vision in the left eye at the age of 57.
On evaluation, laboratory findings detected the elevated serum tumor markers of CA12-5, CA15-3, NSE, and Cyfra21-1. The imaging showed left lung metastase, multiple lymph node metastases, and small suspected metastases in the both sides of parietal lobes. Fundus fluorescein angiography showed choroidal occupying lesion of the left side which indicates secondary metastasis and retinal detachment. Combined with the pathological finding via fiberoptic bronchoscopic biopsy, the patient was clinically diagnosed with a late distant recurrence of breast carcinoma.
The patient received oral endocrine therapy of letrozole, but she refused chemotherapy, radiotherapy and other topical treatments.
At the 3-month follow-up visit, the multiple lesions of the left lung and lymph nodes had partially regressed, and the lesion of right parietal lobe had disappeared. The patient's clinical symptoms, such as blood-tinged sputum and dysphagia, had significantly improved.
We have described this case and reviewed the relevant literature concerning late distant recurrence of breast carcinoma. Importantly, this case indicates that patients with HR positive breast carcinoma are more likely to develop late distant recurrence and clinicians should not ignore the follow-up examinations even more than 20 years after the surgery.
乳腺癌转移至主支气管和脉络膜较为罕见,但相关文献已有报道。乳腺癌术后20多年出现晚期远处复发极为罕见。在此,我们报告一名57岁女性,术后近28年出现晚期远处复发并转移至主支气管和脉络膜。
患者29岁时因右侧乳腺癌行乳房切除术后接受化疗和内分泌治疗。57岁时因咳血痰、吞咽困难和左眼视力模糊入院。
经评估,实验室检查发现血清肿瘤标志物CA12 - 5、CA15 - 3、NSE和Cyfra21 - 1升高。影像学检查显示左肺转移、多发淋巴结转移以及双侧顶叶小的可疑转移灶。眼底荧光血管造影显示左侧脉络膜占位性病变,提示继发性转移和视网膜脱离。结合纤维支气管镜活检的病理结果,患者临床诊断为乳腺癌晚期远处复发。
患者接受来曲唑口服内分泌治疗,但拒绝化疗、放疗及其他局部治疗。
在3个月的随访中,左肺和淋巴结的多处病变部分消退,右侧顶叶病变消失。患者咳血痰和吞咽困难等临床症状明显改善。
我们描述了该病例并回顾了有关乳腺癌晚期远处复发的相关文献。重要的是,该病例表明HR阳性乳腺癌患者更易发生晚期远处复发,临床医生即使在术后20多年也不应忽视随访检查。